Scantox Group acquires Gentronix, a world leader in genetic toxicology

Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO").

Gentronix, now integrated into Scantox Group, is well recognized for its high-quality genetic toxicology services and strong scientific engagement, with an undisputed track record of serving a loyal and broad global customer base. With the acquisition of Gentronix, Scantox s service platform expands sign

Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August 20–22, and at the 36th World Congress of Audiology from September 19–22, 2024.

The PROHEAR study is a placebo-controlled Phase 2a study with split-body design investigating the otoprotective

Labguru (BioData) Announces New Distribution Partnership of its Electronic Lab Notebook Module to Help Streamline Life Sciences Research

Labguru (BioData) Announces New Distribution Partnership of its Electronic Lab Notebook Module to Help Streamline Life Sciences Research

New distribution agreement with Thermo Fisher Scientific allows Thermo Fisher to offer Labguru s cutting-edge Electronic Lab Notebook module together with Thermo Fisher s renowned suite of Laboratory Information Management System (LIMS) and lab operations software solutions, amplifying Labguru s ELN capabilities.

Labguru (https://www.labguru.com/) (BioData) announces an agreement with Thermo Fisher Scientific (https://www.thermofisher.com/) to enable the distribution of its state-of-the-art Lab

Lifespin GmbH and Ac?badem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine

lifespin GmbH, a pioneer in health status detection software, has teamed up with Ac?badem University (ACU) and Ac?badem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revolutionizing personalized healthcare. This collaboration is set to develop and expand the global market for innovative healthcare solutions that utilize a combination of advanced Nuclear Magnetic Resonance (NMR) and AI technologies.

Under the agreement, lifespin GmbH